PTHS · Pelthos Therapeutics Inc. · Analyst Estimates
$20.55
+0.20 (+0.98%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— cleared May 14, 2026
The latest filing states the doubt was alleviated.
“in prior periods, management disclosed substantial doubt about the Company's ability to continue as a going concern. The conditions and events that previously raised substantial doubt have been alleviated by management's plans and actions.”View the 10-Q filed May 14, 2026
Market Cap
$84.95M
Shares
3.83M
Volume · Oct 2
7017
Avg daily vol (3M)
58.45K
Analyst Estimates
Compare analyst forecasts for Pelthos Therapeutics Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-09-18 22:56 UTC · Publication dates shown per estimate · 16 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-27.45
|
-18.82
|
-12.4
|
— |
-18.82
|
-10.6625
|
-18.82
|
-10.6625
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
4
|
— | — | — | — |
2
|
2
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
55768000
|
63746000
|
72100000
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
7
|
— | — | — | — | — | — | — | — |
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-7.76
|
-5.6825
|
-1.45
|
— |
-5.6825
|
-2.125
|
-5.6825
|
-2.125
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
4
|
— | — | — | — |
1
|
1
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
75941000
|
112218000
|
138600000
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
7
|
— | — | — | — | — | — | — | — |
Q ending 2026-09-30
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-4.6
|
-3.34
|
-1.6
|
— |
-3.34
|
-1.8925
|
-3.34
|
-1.8925
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
4
|
— | — | — | — |
1
|
1
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
16700000
|
17962140
|
20600000
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
7
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-4.71
|
-3.12
|
-1.1
|
— |
-3.12
|
-1.965
|
-3.12
|
-1.965
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
4
|
— | — | — | — |
0
|
0
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
12225000
|
19195710
|
25000000
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
7
|
— | — | — | — | — | — | — | — |